Literature DB >> 15032786

Sample size calculations for surveys to substantiate freedom of populations from infectious agents.

Wesley O Johnson1, Chun-Lung Su, Ian A Gardner, Ronald Christensen.   

Abstract

We develop a Bayesian approach to sample size computations for surveys designed to provide evidence of freedom from a disease or from an infectious agent. A population is considered "disease-free" when the prevalence or probability of disease is less than some threshold value. Prior distributions are specified for diagnostic test sensitivity and specificity and we test the null hypothesis that the prevalence is below the threshold. Sample size computations are developed using hypergeometric sampling for finite populations and binomial sampling for infinite populations. A normal approximation is also developed. Our procedures are compared with the frequentist methods of Cameron and Baldock (1998a, Preventive Veterinary Medicine34, 1-17.) using an example of foot-and-mouth disease. User-friendly programs for sample size calculation and analysis of survey data are available at http://www.epi.ucdavis.edu/diagnostictests/.

Entities:  

Mesh:

Year:  2004        PMID: 15032786     DOI: 10.1111/j.0006-341X.2004.00143.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

1.  Operational Performance of the Onchocerca volvulus "OEPA" Ov16 ELISA Serological Assay in Mapping, Guiding Decisions to Stop Mass Drug Administration, and Posttreatment Surveillance Surveys.

Authors:  Frank O Richards; Moses Katabarwa; Firdaweke Bekele; Zerihun Tadesse; Aderajew Mohammed; Mauricio Sauerbrey; Alfredo Dominguez-Vazquez; Mario A Rodriguez-Perez; Nadia A Fernández-Santos; Nidia Rizzo; Harland R Schuler Martínez; Raquel Lovato Silva; Zoraida Morales Monroy; Peace Habomugisha; David W Oguttu; Issam M A Zarroug; Nabil A Aziz; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

2.  Risk-targeted selection of agricultural holdings for post-epidemic surveillance: estimation of efficiency gains.

Authors:  Ian G Handel; Barend M de C Bronsvoort; John F Forbes; Mark E J Woolhouse
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

Review 3.  Diagnostics for onchocerciasis in the era of elimination.

Authors:  Thomas R Unnasch; Allison Golden; Vitaliano Cama; Paul T Cantey
Journal:  Int Health       Date:  2018-03-01       Impact factor: 2.473

4.  Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys.

Authors:  Edwin Michael; Morgan E Smith; Moses N Katabarwa; Edson Byamukama; Emily Griswold; Peace Habomugisha; Thomson Lakwo; Edridah Tukahebwa; Emmanuel S Miri; Abel Eigege; Evelyn Ngige; Thomas R Unnasch; Frank O Richards
Journal:  Nat Commun       Date:  2018-10-18       Impact factor: 14.919

Review 5.  Onchocerciasis Elimination: Progress and Challenges.

Authors:  Thomson Lakwo; David Oguttu; Tony Ukety; Rory Post; Didier Bakajika
Journal:  Res Rep Trop Med       Date:  2020-10-07

6.  China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design.

Authors:  Liping Liu; Yilong Wang; Xuewei Xie; Dacheng Liu; Aili Wang; Penglian Wang; Suwen Shen; Chongke Zhong; Yufei Wei; Tan Xu; Yuesong Pan; Yong Jiang; Xia Meng; David Wang; Yonghong Zhang; Jiang He; Yongjun Wang
Journal:  Stroke Vasc Neurol       Date:  2021-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.